Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.
about
High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.Accelerated immunotherapy schedules.Venom immunotherapy: an updated review.The soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responses.Highlights on the EAACI-WAO Congress 2013.
P2860
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@ast
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@en
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@nl
type
label
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@ast
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@en
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@nl
prefLabel
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@ast
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@en
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@nl
P2093
P2860
P50
P921
P1433
P1476
Effects of different up-dosing ...... apy on serum CTLA-4 and IL-10.
@en
P2093
Anna Maria Riccio
Anthi Rogkakou
Daniele Saverino
Giampaola Pesce
Marcello Bagnasco
Marina Mauro
Maurizio Severino
Patrizia Bonadonna
P2860
P304
P356
10.1371/JOURNAL.PONE.0037980
P407
P577
2012-06-19T00:00:00Z